Table 5. Relative risk for malaria and lymphatic filariasis outcomes one year after an LLIN distribution campaign in Nacala-a-Velha and Mecubúri Districts, Mozambique, as a function of demographic, socioeconomic, and bed net usage factors.

		Antibody seropositivity in 2014
	Malaria RDT+ in 2014	P. falciparum MSP-119	P. falciparum CSP	P. falciparum LSA-1	P. vivax MSP-119	P. ovale MSP-119	P. malariae MSP-119	W. bancrofti Wb123	B. malayi Bm14	B. malayi Bm33
Age
<5 yrs	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
5–10 yrs	1.1 (0.92–1.3)	0.99 (0.8–1.2)	2.1 (1.5–3)	1.1 (0.81–1.6)	2.8 (0.29–27)	1.6 (1.2–2.3)	2.2 (1.6–3.2)	1.0 (0.68–1.6)	2.7 (1.2–6.1)	1.5 (1.1–2.1)
10–15 yrs	1.1 (0.85–1.3)	1.1 (0.84–1.4)	3.4 (2.4–4.8)	1 (0.68–1.6)	4.3 (0.39–48)	1.6 (1.1–2.4)	2.7 (1.8–4)	1.9 (1.2–2.9)	8.9 (4.1–19)	2.1 (1.5–2.9)
15–20 yrs	0.82 (0.61–1.1)	1.2 (0.91–1.6)	4.2 (2.9–6.1)	0.9 (0.52–1.6)	1e-06 (0-Inf)	2.0 (1.3–3.1)	2.8 (1.8–4.4)	3.6 (2.3–5.6)	18 (8.4–39)	3.0 (2.1–4.3)
20–30 yrs	0.56 (0.43–0.73)	1.2 (0.99–1.6)	4.2 (3.1–5.8)	1.6 (1.1–2.3)	7.9 (0.91–67)	1.7 (1.2–2.5)	3.3 (2.3–4.7)	3.5 (2.4–5.2)	15 (7.5–32)	2.6 (1.9–3.5)
30–40 yrs	0.46 (0.34–0.63)	1.3 (1–1.7)	4.4 (3.2–6.2)	1.5 (1.1–2.2)	7.2 (0.8–65)	1.9 (1.3–2.8)	3.6 (2.5–5.2)	3.8 (2.6–5.6)	17 (8.4–36)	2.7 (2–3.6)
>40 yrs	0.31 (0.23–0.42)	1.3 (1.1–1.7)	4.5 (3.3–6.2)	1.8 (1.3–2.5)	6.8 (0.79–59)	2.5 (1.8–3.4)	4.2 (3–5.9)	3.9 (2.7–5.6)	20 (9.7–40)	2.8 (2.1–3.7)
Sex
Female	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
Male	1.0 (0.9–1.2)	0.87 (0.76–0.99)	0.98 (0.85–1.1)	0.92 (0.75–1.1)	1.4 (0.59–3.5)	0.8 (0.66–0.97)	1.0 (0.84–1.2)	1.2 (1–1.5)	1.3 (1–1.6)	0.95 (0.81–1.1)
SES quintile
1st (Poorest)	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
2nd	0.94 (0.75–1.2)	0.96 (0.77–1.2)	1.1 (0.84–1.4)	1.1 (0.82–1.6)	5.7 (0.63–51)	1.2 (0.89–1.7)	1.1 (0.86–1.5)	0.94 (0.68–1.3)	0.80 (0.57–1.1)	1.0 (0.77–1.3)
3rd	0.90 (0.72–1.1)	0.99 (0.8–1.2)	0.99 (0.78–1.2)	0.94 (0.68–1.3)	3.5 (0.36–34)	1.3 (0.94–1.7)	1 (0.78–1.3)	0.93 (0.7–1.2)	0.78 (0.57–1.1)	0.98 (0.76–1.2)
4th	0.87 (0.7–1.1)	0.94 (0.76–1.2)	0.96 (0.76–1.2)	0.89 (0.64–1.2)	7.9 (0.95–65)	1.1 (0.79–1.5)	0.92 (0.71–1.2)	0.91 (0.68–1.2)	0.77 (0.57–1.1)	0.96 (0.75–1.2)
5th (Richest)	0.80 (0.64–0.99)	0.95 (0.78–1.2)	0.96 (0.77–1.2)	1.0 (0.76–1.4)	4.6 (0.52–41)	0.99 (0.73–1.3)	0.87 (0.66–1.1)	0.8 (0.59–1.1)	0.71 (0.52–0.97)	0.98 (0.77–1.3)
LLIN Use (individual)	0.81 (0.64–1.0)	0.99 (0.82–1.2)	0.98 (0.79–1.2)	1.1 (0.82–1.5)	0.85 (0.23–3.1)	1.0 (0.8–1.4)	0.98 (0.76–1.3)	1.1 (0.83–1.4)	0.97 (0.73–1.3)	1.0 (0.81–1.3)
LLIN Use (community)	0.43 (0.24–0.77)	1.0 (0.6–1.7)	0.71 (0.39–1.3)	0.34 (0.15–0.79)	0.22 (0.0062–8)	0.67 (0.31–1.5)	0.4 (0.2–0.81)	2.0 (0.95–4.4)	0.98 (0.43–2.3)	3.7 (2–6.9)

RDT: rapid diagnostic test; SES: socioeconomic status; LLIN: long-lasting insecticidal net